SlideShare une entreprise Scribd logo
1  sur  22
ISO 14971
INTRODUCTION
OVERVIEW
1of 1
• ISO 13485 is an international risk
management standard for medical
devices (including in vitro diagnostic
medical devices).
It defines a set of medical device risk management
requirements.
• The purpose of ISO 14971 is to help
manufacturers to establish a medical
device risk management process that can
be used to identify hazards, to estimate
and evaluate risks, and to implement and
monitor the effectiveness of risk control
measures.
ISO 14971 was first published in 2000. This
second edition was officially published on
March 1, 2007. It cancels and replaces the first
edition. ISO 14971 was developed because no
standard existed at the time and because
regulators throughout the world wanted
manufacturers to apply risk management to
their medical devices.
Definitions
• When the standard development
process began it soon became
obvious that “absolute safety” was
not achievable.
In addition, it became clear that product safety standards
cannot deal with all possible risks. There are just too many
products and applications for a product oriented approach
to work effectively. Because of this, and because there was
a great need to manage risks throughout the entire
product life-cycle, the standards development committee
decided to prepare ISO 14971.
SCOPE
• ISO 14971 applies to all medical
device manufacturers and all
medical devices and should be
used to manage risk throughout
• All stages of the product life-cycle
from initial concept right through
to final disposal..
Since risks can be introduced throughout
the product life-cycle and since risks that
emerge at one point can often be controlled at a
completely different point, ISO 14971 must be
used throughout the product’s entire existence.
However, ISO 14971 does not apply to clinical
decision making. Whether or not a medical
device should be used in the context of a
particular clinical procedure is a matter of
judgment. Such judgments are usually made
by qualified health care professionals and are
not regulated by this international standard.
REGULATORY ENVIRONMENT
• ISO 14971 is widely recognized as
the official standard for medical
device risk management.
Regulators in most major markets
expect medical device
manufacturers to use this standard
to manage risk.
ISO 14971 has been officially recognized by the
U.S. FDA and by Health Canada. In addition, the
European Union has adopted it as a harmonized
standard and Australia and Japan have accepted it
as the official standard for medical device risk
management.
Medical device risk management is now mandatory
in most countries and regions of the world. Every
regulated medical device manufacturer now needs
to be able to prove to regulators that they use risk
management methods to control risk and to ensure
that their products are safe.
FINDS
CERTIFICATION
ISO 14971 does not expect medical device
manufacturers to become certified.
You can simply use the standard to manage
risk and then declare that you are in compliance
(if you can demonstrate that this is in fact true).
However, regulators may require certification
and your customers may be more impressed if an
independent registrar (certification body) has
confirmed that you use the standard to manage
risk and that you actually are in compliance.
While ISO 14971 does not expect you to
become certified, several major registrars
now offer certification services. Some of these
include BSI, Underwriters Laboratories,
INTERINTERTEK, and SGS
STEP-BY-STEP OVERVIEW
ISO 14971 describes a risk management
process (Parts 3 to 9) and is organized in
the following way:
3. Establish your risk management framework.
4. Perform a RISK ANALYSIS for each medical device.
5. Evaluate risk for each identified Hazardous
situation.
6. Develop risk control measures when risk must be
reduced.
7. Evaluate the overall residual risk posed by each
device.
8. Review risk management process and prepare
report.
9. Monitor device during production and post-
production.
1.PRODUCT ORIENTED APPROACH
2.ENTIRE PRODUCT LIFE-CYCLE
Where is 1&2-?
The following diagram summarizes the
ISO 14971-2007risk management process.
It describes the main steps that define
this process, including the sequence that
should be followed, and it highlights key
decision points
Thank you
Prepared & implemented by
Dr. krupasankar,Joint director,
Council of Quality standards India
Tamil Nadu region

Contenu connexe

En vedette

Latitude Pharmaceuticals Overview
Latitude Pharmaceuticals OverviewLatitude Pharmaceuticals Overview
Latitude Pharmaceuticals Overview
Matthew Singer
 
BHRT Transforming Care Plan
BHRT Transforming Care PlanBHRT Transforming Care Plan
BHRT Transforming Care Plan
Dave Clements
 

En vedette (17)

Catalogo Oriente
Catalogo OrienteCatalogo Oriente
Catalogo Oriente
 
C and c of dps
C and c of dpsC and c of dps
C and c of dps
 
BULLYING
BULLYING BULLYING
BULLYING
 
Logbook and evalution
Logbook and evalutionLogbook and evalution
Logbook and evalution
 
2016 Online Video İstatistikleri [İnfografik]
2016 Online Video İstatistikleri [İnfografik]2016 Online Video İstatistikleri [İnfografik]
2016 Online Video İstatistikleri [İnfografik]
 
Piazzasalento n4
Piazzasalento n4Piazzasalento n4
Piazzasalento n4
 
Latitude Pharmaceuticals Overview
Latitude Pharmaceuticals OverviewLatitude Pharmaceuticals Overview
Latitude Pharmaceuticals Overview
 
DINESH PANDITA
DINESH PANDITADINESH PANDITA
DINESH PANDITA
 
BHRT Transforming Care Plan
BHRT Transforming Care PlanBHRT Transforming Care Plan
BHRT Transforming Care Plan
 
Exp. certificates 1 of 2 set
Exp. certificates 1 of 2 setExp. certificates 1 of 2 set
Exp. certificates 1 of 2 set
 
Evaluation q 5
Evaluation q 5Evaluation q 5
Evaluation q 5
 
Piazzasalento n 20
Piazzasalento n 20Piazzasalento n 20
Piazzasalento n 20
 
دانلود ترجمه انگلیسی دیپلم
دانلود ترجمه انگلیسی دیپلمدانلود ترجمه انگلیسی دیپلم
دانلود ترجمه انگلیسی دیپلم
 
2016 yılında görsel i̇çer i̇k hakkında bi̇lmeni̇z gereken i̇stati̇sti̇kler
2016 yılında görsel i̇çer i̇k hakkında bi̇lmeni̇z gereken i̇stati̇sti̇kler2016 yılında görsel i̇çer i̇k hakkında bi̇lmeni̇z gereken i̇stati̇sti̇kler
2016 yılında görsel i̇çer i̇k hakkında bi̇lmeni̇z gereken i̇stati̇sti̇kler
 
tokoh matematik
tokoh matematiktokoh matematik
tokoh matematik
 
Mandamientos1
Mandamientos1Mandamientos1
Mandamientos1
 
Latihan Ithink and kbat math form 2
Latihan Ithink and kbat math form 2Latihan Ithink and kbat math form 2
Latihan Ithink and kbat math form 2
 

Similaire à Risk-4-medi-mgmt

Pharmacovigilance and Drug safety
Pharmacovigilance and Drug safety Pharmacovigilance and Drug safety
Pharmacovigilance and Drug safety
ClinosolIndia
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safety
Azierta
 
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Bhaswat Chakraborty
 

Similaire à Risk-4-medi-mgmt (20)

Risk managements documents required for the market placement of a medical dev...
Risk managements documents required for the market placement of a medical dev...Risk managements documents required for the market placement of a medical dev...
Risk managements documents required for the market placement of a medical dev...
 
ICH Guidelines for Pharmacovigilance
ICH Guidelines for PharmacovigilanceICH Guidelines for Pharmacovigilance
ICH Guidelines for Pharmacovigilance
 
PECB Webinar: Hands on medical devices risk assessment
PECB Webinar: Hands on medical devices risk assessmentPECB Webinar: Hands on medical devices risk assessment
PECB Webinar: Hands on medical devices risk assessment
 
2021_2_1_PDF_WM.pdf
2021_2_1_PDF_WM.pdf2021_2_1_PDF_WM.pdf
2021_2_1_PDF_WM.pdf
 
Application of Risk Management to Medical Devices in the EU
Application of Risk Management to Medical Devices in the EUApplication of Risk Management to Medical Devices in the EU
Application of Risk Management to Medical Devices in the EU
 
Pharmacovigilance and Drug safety
Pharmacovigilance and Drug safety Pharmacovigilance and Drug safety
Pharmacovigilance and Drug safety
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safety
 
ISO 13485 Certification.pdf
ISO 13485 Certification.pdfISO 13485 Certification.pdf
ISO 13485 Certification.pdf
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance ppt
 
Pharmacovigilance Planning
Pharmacovigilance PlanningPharmacovigilance Planning
Pharmacovigilance Planning
 
assinment signal.pptx
assinment signal.pptxassinment signal.pptx
assinment signal.pptx
 
Changes in European PV post July 2011
Changes in European PV post July 2011Changes in European PV post July 2011
Changes in European PV post July 2011
 
ISO 13485 Medical Manufature.pdf
ISO 13485 Medical Manufature.pdfISO 13485 Medical Manufature.pdf
ISO 13485 Medical Manufature.pdf
 
Safety report filing
Safety report filingSafety report filing
Safety report filing
 
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
 
Lancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshopLancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshop
 
Medical Product Development cycle
Medical Product Development cycleMedical Product Development cycle
Medical Product Development cycle
 
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
Cathal Brennan , Medical Device Assessor- Human Products Authorisation and Re...
 
ISO 15000:1998 and ISO 18001:2007
ISO 15000:1998 and ISO 18001:2007ISO 15000:1998 and ISO 18001:2007
ISO 15000:1998 and ISO 18001:2007
 
Closing Messages
Closing MessagesClosing Messages
Closing Messages
 

Risk-4-medi-mgmt

  • 2. 1of 1 • ISO 13485 is an international risk management standard for medical devices (including in vitro diagnostic medical devices).
  • 3. It defines a set of medical device risk management requirements. • The purpose of ISO 14971 is to help manufacturers to establish a medical device risk management process that can be used to identify hazards, to estimate and evaluate risks, and to implement and monitor the effectiveness of risk control measures.
  • 4. ISO 14971 was first published in 2000. This second edition was officially published on March 1, 2007. It cancels and replaces the first edition. ISO 14971 was developed because no standard existed at the time and because regulators throughout the world wanted manufacturers to apply risk management to their medical devices.
  • 5. Definitions • When the standard development process began it soon became obvious that “absolute safety” was not achievable.
  • 6. In addition, it became clear that product safety standards cannot deal with all possible risks. There are just too many products and applications for a product oriented approach to work effectively. Because of this, and because there was a great need to manage risks throughout the entire product life-cycle, the standards development committee decided to prepare ISO 14971.
  • 7. SCOPE • ISO 14971 applies to all medical device manufacturers and all medical devices and should be used to manage risk throughout • All stages of the product life-cycle from initial concept right through to final disposal..
  • 8. Since risks can be introduced throughout the product life-cycle and since risks that emerge at one point can often be controlled at a completely different point, ISO 14971 must be used throughout the product’s entire existence.
  • 9. However, ISO 14971 does not apply to clinical decision making. Whether or not a medical device should be used in the context of a particular clinical procedure is a matter of judgment. Such judgments are usually made by qualified health care professionals and are not regulated by this international standard.
  • 10. REGULATORY ENVIRONMENT • ISO 14971 is widely recognized as the official standard for medical device risk management. Regulators in most major markets expect medical device manufacturers to use this standard to manage risk.
  • 11. ISO 14971 has been officially recognized by the U.S. FDA and by Health Canada. In addition, the European Union has adopted it as a harmonized standard and Australia and Japan have accepted it as the official standard for medical device risk management.
  • 12. Medical device risk management is now mandatory in most countries and regions of the world. Every regulated medical device manufacturer now needs to be able to prove to regulators that they use risk management methods to control risk and to ensure that their products are safe.
  • 14. ISO 14971 does not expect medical device manufacturers to become certified. You can simply use the standard to manage risk and then declare that you are in compliance (if you can demonstrate that this is in fact true).
  • 15. However, regulators may require certification and your customers may be more impressed if an independent registrar (certification body) has confirmed that you use the standard to manage risk and that you actually are in compliance.
  • 16. While ISO 14971 does not expect you to become certified, several major registrars now offer certification services. Some of these include BSI, Underwriters Laboratories, INTERINTERTEK, and SGS
  • 17. STEP-BY-STEP OVERVIEW ISO 14971 describes a risk management process (Parts 3 to 9) and is organized in the following way:
  • 18. 3. Establish your risk management framework. 4. Perform a RISK ANALYSIS for each medical device. 5. Evaluate risk for each identified Hazardous situation. 6. Develop risk control measures when risk must be reduced. 7. Evaluate the overall residual risk posed by each device. 8. Review risk management process and prepare report. 9. Monitor device during production and post- production.
  • 19. 1.PRODUCT ORIENTED APPROACH 2.ENTIRE PRODUCT LIFE-CYCLE Where is 1&2-?
  • 20. The following diagram summarizes the ISO 14971-2007risk management process. It describes the main steps that define this process, including the sequence that should be followed, and it highlights key decision points
  • 21.
  • 22. Thank you Prepared & implemented by Dr. krupasankar,Joint director, Council of Quality standards India Tamil Nadu region